Cargando…
Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer
It is crucial to find new diagnostic and prognostic biomarkers. A total of 80 patients were enrolled in the study. The study group consisted of 37 patients with epithelial ovarian cancer, and the control group consisted of 43 patients with benign ovarian cystic lesions. Three proteins involved in th...
Autores principales: | Świderska, Janina, Kozłowski, Mateusz, Nowak, Katarzyna, Rychlicka, Małgorzata, Branecka-Woźniak, Dorota, Kwiatkowski, Sebastian, Pius-Sadowska, Ewa, Machaliński, Bogusław, Cymbaluk-Płoska, Aneta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774466/ https://www.ncbi.nlm.nih.gov/pubmed/35054356 http://dx.doi.org/10.3390/diagnostics12010189 |
Ejemplares similares
-
Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022) -
Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points
por: Świderska, Janina, et al.
Publicado: (2021) -
Could Vaspin Be a Potential Diagnostic Marker in Endometrial Cancer?
por: Pietrzyk, Dominika, et al.
Publicado: (2023) -
Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis?
por: Toledo, Andrea, et al.
Publicado: (2023) -
Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022)